Table 2 Clinical and Pathological Characteristics of the Patients (Male)
Parameter | Anastomotic leakage (+) | Anastomotic leakage (−) | p |
|---|---|---|---|
n = 18 | n = 82 | ||
Age, yr., mean ± SD (median, range) | 64.7 ± 7.3 (63, 52–79) | 66.1 ± 11.2 (68, 38–87) | 0.38 |
BMI, kg/m2, mean ± SD (median, range) | 23.5 ± 3.7 (22.9, 15.2–28.6) | 23.3 ± 3.2 (23.1, 16.8–33.6) | 0.58 |
BMI, ≥ 25, n (%) | 8 (44) | 21 (26) | 0.15 |
ASA | Â | Â | 1.00 |
 1 | 2 (11) | 11 (13) |  |
 2 | 15 (83) | 64 (78) |  |
 3 | 1 (6) | 7 (9) |  |
Tumor location (from the anal verge), n (%) | Â | Â | 0.49 |
 Upper (10–15 cm) | 5 (28) | 35 (43) |  |
 Middle (5–10 cm) | 9 (50) | 32 (39) |  |
 Lower (< 5 cm) | 4 (13) | 15 (18) |  |
Tumor size, mm, mean ± SD (median, range) | 45.6 ± 19.3 (50, 7–80) | 39.7 ± 22.3 (35, 8–170) | 0.14 |
UICC-TNM Stage, n (%) | Â | Â | 0.71 |
 0 | 0 (0) | 1 (1) |  |
 I | 6 (33) | 23 (28) |  |
 II | 5 (28) | 25 (30) |  |
 III | 3 (17) | 22 (27) |  |
 IV | 4 (22) | 11 (13) |  |
T category, n (%) | Â | Â | 0.56 |
 Tis | 0 (0) | 1 (1) |  |
 T1 | 2 (11) | 11 (13) |  |
 T2 | 4 (22) | 20 (24) |  |
 T3 | 11 (61) | 40 (49) |  |
 T4 | 0 (0) | 10 (12) |  |
N category, n (%) | Â | Â | 0.87 |
 N0 | 11 (61) | 53 (65) |  |
 N1 | 5 (28) | 20 (24) |  |
 N2 | 2 (11) | 6 (7) |  |
 N3 | 0 (0) | 3 (4) |  |
M category, n (%) | Â | Â | 0.46 |
 M0 | 14 (78) | 71 (87) |  |
 M1 | 4 (22) | 11 (13) |  |
Preoperative chemotherapy, n (%) | 1 (6) | 7 (9) | 1.00 |
Preoperative decompression, n (%) | 0 (0) | 2 (2) | 1.00 |
WBC, ×102/μl, mean ± SD | 69.7 ± 15.2 | 64.6 ± 15.4 | 0.21 |
Plt, ×104/μl, mean ± SD | 26.4 ± 10.6 | 23.6 ± 5.7 | 0.13 |
Creatinine, mg/dl, mean ± SD | 1.05 ± 0.51 | 0.89 ± 0.21 | 0.03 |
Total cholesterol, mg/dl, mean ± SD | 177 ± 52 | 187 ± 30 | 0.31 |
Triglyceride, mg/dl, mean ± SD | 128 ± 68 | 124 ± 62 | 0.81 |
Total protein, g/dl, mean ± SD | 7.0 ± 0.4 | 7.8 ± 7.5 | 0.65 |
Albumin, g/dl, mean ± SD | 3.9 ± 0.5 | 4.6 ± 4.9 | 0.54 |
Blood sugar, mg/dl, mean ± SD | 127 ± 44 | 113 ± 35 | 0.20 |